Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
68,037,614
-
Share change
-
+19,114,091
-
Total reported value
-
$440,110,027
-
Put/Call ratio
-
56%
-
Price per share
-
$6.47
-
Number of holders
-
124
-
Value change
-
+$135,960,219
-
Number of buys
-
74
-
Number of sells
-
45
Institutional Holders of IMMUNOMEDICS INC - COM (IMMU) as of Q1 2017
As of 31 Mar 2017 IMMUNOMEDICS INC - COM (IMMU) had 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 68,037,614 shares of stock of the company.
Largest 10 holders included venBio Select Advisor LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, STATE STREET CORP, Redmile Group, LLC, First Light Asset Management, LLC, MILLENNIUM MANAGEMENT LLC, and ArrowMark Colorado Holdings LLC.
This table shows 124 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.